Regulatory Affairs

The Regulatory Affairs team at NeuroSense Therapeutics is responsible for navigating the complex landscape of regulatory requirements to ensure the successful development and approval of innovative treatments for neurodegenerative diseases, including ALS. This team collaborates closely with clinical and manufacturing teams, leading the submission of regulatory documents and managing communication with health authorities to facilitate timely progress through clinical trials and product approvals. Their expertise is crucial in aligning the company’s drug development strategy with regulatory standards, ensuring compliance, and ultimately advancing patient access to new therapies.